Conyers Dill & Pearman provided Cayman legal advice to BBI Life Sciences Corporation on its HK$229.54million IPO on the Main Board of The Stock Exchange of Hong Kong (HKSE). BBI operates in the life sciences research products and services industry and provides laboratory services and products to hospitals, pharmaceutical and biotech companies, government testing and diagnostics centres, and distributors in China and overseas.
Bernadette Chen of Conyers’ Hong Kong office advised on the matter, working alongside Howse Williams Bowers, King & Wood Mallesons, OFSINK LLC, McMillan LLP and DLA Piper.
